Ferrochelatase is a therapeutic target for ocular neovascularization

Ocular neovascularization underlies major blinding eye diseases such as “wet” age‐related macular degeneration (AMD). Despite the successes of treatments targeting the vascular endothelial growth factor (VEGF) pathway, resistant and refractory patient populations necessitate discovery of new therape...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:EMBO Mol Med
Huvudupphovsmän: Basavarajappa, Halesha D, Sulaiman, Rania S, Qi, Xiaoping, Shetty, Trupti, Sheik Pran Babu, Sardar, Sishtla, Kamakshi L, Lee, Bit, Quigley, Judith, Alkhairy, Sameerah, Briggs, Christian M, Gupta, Kamna, Tang, Buyun, Shadmand, Mehdi, Grant, Maria B, Boulton, Michael E, Seo, Seung‐Yong, Corson, Timothy W
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2017
Ämnen:
Research Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5452042/
https://ncbi.nlm.nih.gov/pubmed/28377496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201606561
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk